Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 May 19;300(6735):1289–1290. doi: 10.1136/bmj.300.6735.1289

The penicillins today.

R Finch 1
PMCID: PMC1663030  PMID: 2196095

Full text

PDF
1289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelbaum P. C. World-wide development of antibiotic resistance in pneumococci. Eur J Clin Microbiol. 1987 Aug;6(4):367–377. doi: 10.1007/BF02013089. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Bolivar R., Fainstein V., Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis. 1983 Mar-Apr;5(2):279–313. doi: 10.1093/clinids/5.2.279. [DOI] [PubMed] [Google Scholar]
  3. Botha P. Penicillin-resistant Neisseria meningitidis in southern Africa. Lancet. 1988 Jan 2;1(8575-6):54–54. doi: 10.1016/s0140-6736(88)91029-x. [DOI] [PubMed] [Google Scholar]
  4. Brown R. M., Wise R., Andrews J. M. Temocillin, in-vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers. J Antimicrob Chemother. 1982 Oct;10(4):295–302. doi: 10.1093/jac/10.4.295. [DOI] [PubMed] [Google Scholar]
  5. Cabizuca S. V., Desser K. B. Carbenicillin-associated hypokalemic alkalosis. JAMA. 1976 Aug 23;236(8):956–957. [PubMed] [Google Scholar]
  6. Eliopoulos G. M., Moellering R. C., Jr Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins. Ann Intern Med. 1982 Nov;97(5):755–760. doi: 10.7326/0003-4819-97-5-755. [DOI] [PubMed] [Google Scholar]
  7. Farmer T. H., Reading C. Induction of the beta-lactamases of a strain of Pseudomonas aeruginosa, Morganella morganii and Enterobacter cloacae. J Antimicrob Chemother. 1987 Mar;19(3):401–404. doi: 10.1093/jac/19.3.401. [DOI] [PubMed] [Google Scholar]
  8. Finch R. Is pneumococcal infection a preventable disease? J Infect. 1988 Sep;17(2):95–98. doi: 10.1016/s0163-4453(88)91459-4. [DOI] [PubMed] [Google Scholar]
  9. Greenwood D., Eley A. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics. J Infect Dis. 1982 Jan;145(1):110–117. doi: 10.1093/infdis/145.1.110. [DOI] [PubMed] [Google Scholar]
  10. Gribble M. J., Chow A. W., Naiman S. C., Smith J. A., Bowie W. R., Sacks S. L., Grossman L., Buskard N., Growe G. H., Plenderleith L. H. Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Antimicrob Agents Chemother. 1983 Sep;24(3):388–393. doi: 10.1128/aac.24.3.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ison C. A., Easmon C. S. Changes in penicillinase-producing Neisseria gonorrhoeae isolated in London. J Med Microbiol. 1989 Dec;30(4):239–244. doi: 10.1099/00222615-30-4-239. [DOI] [PubMed] [Google Scholar]
  12. Issell B. F., Bodey G. P. Mezlocillin for treatment of infections in cancer patients. Antimicrob Agents Chemother. 1980 Jun;17(6):1008–1013. doi: 10.1128/aac.17.6.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jules K., Neu H. C. Antibacterial activity and beta-lactamase stability of temocillin. Antimicrob Agents Chemother. 1982 Sep;22(3):453–460. doi: 10.1128/aac.22.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Livermore D. M. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. Eur J Clin Microbiol. 1987 Aug;6(4):439–445. doi: 10.1007/BF02013107. [DOI] [PubMed] [Google Scholar]
  15. Lovering A. M., Bywater M. J., Holt H. A., Champion H. M., Reeves D. S. Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres. J Antimicrob Chemother. 1988 Dec;22(6):823–839. doi: 10.1093/jac/22.6.823. [DOI] [PubMed] [Google Scholar]
  16. Lyon B. R., Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev. 1987 Mar;51(1):88–134. doi: 10.1128/mr.51.1.88-134.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McLeod D. T., Ahmad F., Capewell S., Croughan M. J., Calder M. A., Seaton A. Increase in bronchopulmonary infection due to branhamella catarrhalis. Br Med J (Clin Res Ed) 1986 Apr 26;292(6528):1103–1105. doi: 10.1136/bmj.292.6528.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nafziger D. A., Wenzel R. P. Coagulase-negative staphylococci. Epidemiology, evaluation, and therapy. Infect Dis Clin North Am. 1989 Dec;3(4):915–929. [PubMed] [Google Scholar]
  19. Neu H. C., Labthavikul P. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability. Antimicrob Agents Chemother. 1982 Jan;21(1):180–187. doi: 10.1128/aac.21.1.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Penicillin-resistant strains of Neisseria meningitidis in Spain. Lancet. 1988 Jun 25;1(8600):1452–1453. [PubMed] [Google Scholar]
  21. Powell M. Antimicrobial resistance in Haemophilus influenzae. J Med Microbiol. 1988 Oct;27(2):81–87. doi: 10.1099/00222615-27-2-81. [DOI] [PubMed] [Google Scholar]
  22. Renneberg J., Forsgren A. The activity of isoxazolyl penicillins in experimental staphylococcal infection. J Infect Dis. 1989 Jun;159(6):1128–1132. doi: 10.1093/infdis/159.6.1128. [DOI] [PubMed] [Google Scholar]
  23. Rolinson G. N. Beta-lactamase induction and resistance to beta-lactam antibiotics. J Antimicrob Chemother. 1989 Jan;23(1):1–2. doi: 10.1093/jac/23.1.1. [DOI] [PubMed] [Google Scholar]
  24. Steere A. C. Lyme disease. N Engl J Med. 1989 Aug 31;321(9):586–596. doi: 10.1056/NEJM198908313210906. [DOI] [PubMed] [Google Scholar]
  25. Sutcliffe E. M., Jones D. M., el-Sheikh S., Percival A. Penicillin-insensitive meningococci in the UK. Lancet. 1988 Mar 19;1(8586):657–658. doi: 10.1016/s0140-6736(88)91469-9. [DOI] [PubMed] [Google Scholar]
  26. Thompson M. I., Russo M. E., Saxon B. J., Atkin-Thor E., Matsen J. M. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother. 1982 Feb;21(2):268–273. doi: 10.1128/aac.21.2.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Watt G., Padre L. P., Tuazon M. L., Calubaquib C., Santiago E., Ranoa C. P., Laughlin L. W. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet. 1988 Feb 27;1(8583):433–435. doi: 10.1016/s0140-6736(88)91230-5. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES